Alliance for Pandemic Preparedness
May 18, 2021
Individuals Who Were Mildly Symptomatic Following Infection with SARS-CoV-2 B.1.1.28 Have Neutralizing Antibodies to the P.1 Variant
Category: Article Summary
Topic: Vaccines and Immunity
Keywords (Tags): antibodies, immune response, immunity
- [Pre-print, not peer-reviewed] 84% of sera from to individuals (n=60) recovered from mild SARS-CoV-2 infection caused by the B.1.1.28 variant (the wild-type strain circulating in Brazil) had neutralizing antibodies against the P.1 variant of concern. Neutralization titers against the wild-type strain were consistently higher compared to the P.1 variant, but the differences were not more than a single dilution in over half of samples.
Mendes-Correa et al. (May 17, 2021). Individuals Who Were Mildly Symptomatic Following Infection with SARS-CoV-2 B.1.1.28 Have Neutralizing Antibodies to the P.1 Variant. Pre-print downloaded May 18 from https://doi.org/10.1101/2021.05.11.21256908